BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27035928)

  • 1. A robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers.
    Gomez-Rueda H; Palacios-Corona R; Gutiérrez-Hermosillo H; Trevino V
    Int J Mol Med; 2016 May; 37(5):1355-62. PubMed ID: 27035928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.
    Giannini R; Torregrossa L; Gottardi S; Fregoli L; Borrelli N; Savino M; Macerola E; Vitti P; Miccoli P; Basolo F
    Cancer Cytopathol; 2015 Aug; 123(8):461-70. PubMed ID: 26033834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
    N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
    Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-gene panel that distinguishes benign from malignant thyroid nodules.
    Zheng B; Liu J; Gu J; Lu Y; Zhang W; Li M; Lu H
    Int J Cancer; 2015 Apr; 136(7):1646-54. PubMed ID: 25175491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?
    Yang SE; Sullivan PS; Zhang J; Govind R; Levin MR; Rao JY; Moatamed NA
    Cancer Cytopathol; 2016 Feb; 124(2):100-9. PubMed ID: 26422098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.
    Cantara S; Capezzone M; Marchisotta S; Capuano S; Busonero G; Toti P; Di Santo A; Caruso G; Carli AF; Brilli L; Montanaro A; Pacini F
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1365-9. PubMed ID: 20130073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnostic gene expression thyroid testing.
    Steward DL; Kloos RT
    Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis.
    Wiseman SM; Haddad Z; Walker B; Vergara IA; Sierocinski T; Crisan A; Ghadessi M; Dao P; Zimmermann B; Triche TJ; Erho N; Davicioni E
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4072-9. PubMed ID: 23928671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to approach thyroid nodules with indeterminate cytology.
    Yoon JH; Kwak JY; Kim EK; Moon HJ; Kim MJ; Kim JY; Koo HR; Kim MH
    Ann Surg Oncol; 2010 Aug; 17(8):2147-55. PubMed ID: 20217250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
    Keutgen XM; Filicori F; Fahey TJ
    Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic markers and prognostic factors in thyroid cancer.
    Vriens MR; Schreinemakers JM; Suh I; Guerrero MA; Clark OH
    Future Oncol; 2009 Oct; 5(8):1283-93. PubMed ID: 19852742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.